Lv54
1260 积分 2025-10-09 加入
Can we de-escalate HCC surveillance after 10 years of HBV suppression on nucleos(t)ide analogues?
11小时前
待确认
Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure
1天前
待确认
Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy
3天前
已完结
HBsAg Loss and Hepatocellular Carcinoma Surveillance: One Size Does Not Fit All
8天前
已完结
Fibrosis-driven hepatocarcinogenesis, metastasis and immune evasion: Mechanisms and therapeutic targets
30天前
已完结
Public health opportunities to reduce the global burden of hepatocellular carcinoma
1个月前
已完结
Hepatocellular carcinoma development after hepatitis B surface antigen seroclearance in chronic hepatitis B patients: a 10-year single-center cohort study
1个月前
已完结
Droplet Digital PCR Measurement of HBV DNA in On‐Treatment Chronic HBV Patients: Association With HCC Development and Outcomes
1个月前
已完结
Long-term incidence of hepatocellular carcinoma after hepatitis B surface antigen seroclearance
1个月前
已关闭
Hepatocellular Carcinoma Risk Between Untreated Immune Tolerant Vs. Treated Immune Active Chronic Hepatitis B Patients
1个月前
已完结
皖公网安备34019202002308
